Perioperative Insulin, GIK or GLP-1 Treatment in Diabetes Mellitus
Status:
Completed
Trial end date:
2017-01-01
Target enrollment:
Participant gender:
Summary
The incidence of diabetes mellitus type II is increasing. More and more patients who need
surgery have diabetes mellitus type II. Despite an enormous amount of glucose lowering
protocols and the proven negative effects of hyperglycaemia. There is no evidence for the
optimal glucose lowering protocol.
This study investigates the optimal intraoperative treatment algorithm to lower glucose in
patients with diabetes mellitus type 2 undergoing non-cardiac surgery, comparing
intraoperative glucose-insulin-potassium infusion (GIK), insulin bolus regimen (BR) and GLP-1
(liraglutide, LG) treatment.
Phase:
N/A
Details
Lead Sponsor:
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)